Researchers at the National Jewish Medical and Research Center (NJMRC) have demonstrated that bleach not only kills common household mold, but may also neutralize the mold allergens that cause most mold-related health complaints. The study, published in the September issue of The Journal of Allergy and Clinical Immunology, is the first to test the effect on allergic individuals of mold spores treated with common household bleach.
We have known that bleach can kill mold, however dead mold may often remain allergenic," said lead author Dr. John Martyny, PhD, associate professor of medicine at NJMRC. "With these new findings, it appears that mold treated with bleach lowers allergic reactions, under laboratory conditions, in patients allergic to mold.
The need for denaturing or neutralizing mold allergens is a critical step in mold treatment that has not been fully understood, Martyny said. Currently most recommendations for mold remediation stop at simple removal or killing of mold when dead mold retains its ability to trigger allergic reactions, according to Martyny.
NJMRC researchers began by growing the common fungus Aspergillus fumigatus on building materials for two weeks, and then sprayed some with a household bleach solution (1:16 bleach to water), some with Tilex® Mold & Mildew Remover, a cleaning product containing both bleach and detergent, and others only with distilled water as a control.Â
The researchers then took the mold and conducted standard skin-prick tests on allergy-sensitive patients. Seven of the eight allergic individuals did not react to the bleach-treated building materials, and six did not react to the Tilex-treated building materials. The results suggest that, under laboratory conditions, fungal-contaminated building materials treated with dilute bleach or a bleach-based product, may have significantly reduced allergic health effects.
In order to assure that the bleach solutions will function similarly under actual field conditions, additional experiments will need to be conducted, said Martyny. We do believe that there is strong evidence that bleach can significantly reduce the allergenic properties of common household mold under some conditions.
This study was partially funded by a grant from the Clorox Company.
Â
Â
Â
Â
Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.